These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 6473117)
1. Relation of myocardial blood flow and initial cardiac uptake of 15-(p-123I-phenyl)-pentadecanoic acid in the canine heart. Reske SN; Schön S; Knust EJ; Machulla HJ; Eichelkraut W; Hahn N; Winkler C Nuklearmedizin; 1984 Apr; 23(2):83-5. PubMed ID: 6473117 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of DMIPP uptake and its relationship with heterogeneous myocardial blood flow. Sloof GW; Visser FC; Comans EF; Groeneveld AB; Bax JJ; van Eenige MJ; van der Vusse GJ; Knapp FF J Nucl Med; 1997 Sep; 38(9):1424-30. PubMed ID: 9293802 [TBL] [Abstract][Full Text] [Related]
3. Assessment of myocardial viability using 123I-labeled iodophenylpentadecanoic acid at sustained low flow or after acute infarction and reperfusion. Yang JY; Ruiz M; Calnon DA; Watson DD; Beller GA; Glover DK J Nucl Med; 1999 May; 40(5):821-8. PubMed ID: 10319757 [TBL] [Abstract][Full Text] [Related]
4. Iodophenylpentadecanoic acid-myocardial blood flow relationship during maximal exercise with coronary occlusion. Caldwell JH; Martin GV; Link JM; Krohn KA; Bassingthwaighte JB J Nucl Med; 1990 Jan; 31(1):99-105. PubMed ID: 2295946 [TBL] [Abstract][Full Text] [Related]
5. Correlation of myocardial p-(123)I-iodophenylpentadecanoic acid retention with (18)F-FDG accumulation during experimental low-flow ischemia. Shi CQ; Young LH; Daher E; DiBella EV; Liu YH; Heller EN; Zoghbi S; Wackers FJ; Soufer R; Sinusas AJ J Nucl Med; 2002 Mar; 43(3):421-31. PubMed ID: 11884504 [TBL] [Abstract][Full Text] [Related]
6. Effects of delayed preconditioning on myocardial regional contractility during repeated episodes of low-flow ischaemia in anaesthetized dogs: possible role of nitric oxide. Szigeti Z; Simon K; Parratt JR; Végh A Clin Sci (Lond); 2004 Feb; 106(2):201-13. PubMed ID: 14556644 [TBL] [Abstract][Full Text] [Related]
7. [Effects of gallopamil on iodine-123-phenyl-pentadecanoic acid and thallium 201 uptake in patients with coronary heart disease]. Tillmanns H; Zimmermann R; Kapp M; Rauch B; Neumann FJ; Schlumpp K; Bubeck B; Georgi P; Kübler W Z Kardiol; 1989; 78 Suppl 5():77-82. PubMed ID: 2698567 [TBL] [Abstract][Full Text] [Related]
8. Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium. Einzig S; Sotomora R; Rao GH; Gerrard JM; Foker JE; White JG Prostaglandins Med; 1980 Sep; 5(3):209-19. PubMed ID: 6997909 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of 15-(123I)-p-iodophenyl pentadecanoic acid (IPPA) in assessing myocardial metabolism in a model of reversible global ischemia. Hudon MP; Lyster DM; Jamieson EW; Qayumi KA; Kiess MC; Rosado LJ; Autor AP; Sartori C; Dougan H; van den Broek J Eur J Nucl Med; 1988; 14(12):594-9. PubMed ID: 3243307 [TBL] [Abstract][Full Text] [Related]
10. Effect of myocardial perfusion and metabolic interventions on cardiac kinetics of phenylpentadecanoic acid (IPPA) I 123. Reske SN; Schön S; Schmitt W; Machulla HJ; Knopp R; Winkler C Eur J Nucl Med; 1986; 12 Suppl():S27-31. PubMed ID: 3490375 [TBL] [Abstract][Full Text] [Related]
11. 15-(ortho-123I-phenyl)-pentadecanoic acid, a new myocardial imaging agent for clinical use. Antar MA; Spohr G; Herzog HH; Kaiser KP; Notohamiprodjo G; Vester E; Schwartzkopf B; Lösse B; Machulla HJ; Shreeve WW Nucl Med Commun; 1986 Sep; 7(9):683-96. PubMed ID: 3774263 [TBL] [Abstract][Full Text] [Related]
12. The metabolism of 15-p-[123I]-iodophenylpentadecanoic acid in a surgically induced canine model of regional ischemia. Hudon MP; Lyster DM; Jamieson WR; Qayumi AK; Sartori C; Dougan H Eur J Nucl Med; 1990; 16(4-6):199-204. PubMed ID: 2351167 [TBL] [Abstract][Full Text] [Related]
13. Double-nuclide study of the myocardium using 201Tl and 123I-labeled fatty acids in non-ischemic myocardial diseases. Knapp WH; Vyska K; Machulla HJ; Notohamiprodjo G; Schmidt U; Knust EJ; Gleichmann U Nuklearmedizin; 1988 Jun; 27(3):72-8. PubMed ID: 3405780 [TBL] [Abstract][Full Text] [Related]
14. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)]. Nakaya H Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455 [TBL] [Abstract][Full Text] [Related]
15. 123I-phenylpentadecanoic acid as a tracer of cardiac free fatty acid metabolism. Experimental and clinical results. Reske SN Eur Heart J; 1985 Aug; 6 Suppl B():39-47. PubMed ID: 3936714 [TBL] [Abstract][Full Text] [Related]
16. Assessment of regional myocardial uptake and metabolism of omega-(p-123I-phenyl) pentadecanoic acid with serial single-photon emission tomography. Reske SN; Biersack HJ; Lackner K; Machulla HJ; Knopp R; Hahn N; Winkler C Nuklearmedizin; 1982 Dec; 21(6):249-53. PubMed ID: 6984753 [TBL] [Abstract][Full Text] [Related]
17. Experimental and clinical experience with iodine 123-labeled iodophenylpentadecanoic acid in cardiology. Reske SN J Nucl Cardiol; 1994; 1(2 Pt 2):S58-64. PubMed ID: 9420699 [TBL] [Abstract][Full Text] [Related]
18. Standardized noninvasive assessment of myocardial free fatty acid kinetics by means of 15-(p-iodo-phenyl) pentadecanoic acid (123I-pPPA) scintigraphy: II. Clinical results. Wieler H; Kaiser KP; Kuikka JT; Henkel B; Frank J; Ladwein K Nucl Med Commun; 1992 Mar; 13(3):168-85. PubMed ID: 1557216 [TBL] [Abstract][Full Text] [Related]